These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22612853)

  • 21. From narrative descriptions to MedDRA: automagically encoding adverse drug reactions.
    Combi C; Zorzi M; Pozzani G; Moretti U; Arzenton E
    J Biomed Inform; 2018 Aug; 84():184-199. PubMed ID: 29981491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New adaptive lasso approaches for variable selection in automated pharmacovigilance signal detection.
    Courtois É; Tubert-Bitter P; Ahmed I
    BMC Med Res Methodol; 2021 Dec; 21(1):271. PubMed ID: 34852782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records.
    Liu M; McPeek Hinz ER; Matheny ME; Denny JC; Schildcrout JS; Miller RA; Xu H
    J Am Med Inform Assoc; 2013 May; 20(3):420-6. PubMed ID: 23161894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statistical and graphical approaches for disproportionality analysis of spontaneously-reported adverse events in pharmacovigilance.
    Zink RC; Huang Q; Zhang LY; Bao WJ
    Chin J Nat Med; 2013 May; 11(3):314-20. PubMed ID: 23725848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse event classification and signal detection of data from the customer service and pharmacovigilance of a multinational veterinary pharmaceutical company.
    Marcon DS; Queiroz MR; Baquero OS
    Prev Vet Med; 2022 Sep; 206():105704. PubMed ID: 35850073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uses of pharmacovigilance databases: An overview.
    Bihan K; Lebrun-Vignes B; Funck-Brentano C; Salem JE
    Therapie; 2020; 75(6):591-598. PubMed ID: 32169289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre.
    Théophile H; Arimone Y; Miremont-Salamé G; Moore N; Fourrier-Réglat A; Haramburu F; Bégaud B
    Drug Saf; 2010 Nov; 33(11):1045-54. PubMed ID: 20925441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database.
    Szarfman A; Machado SG; O'Neill RT
    Drug Saf; 2002; 25(6):381-92. PubMed ID: 12071774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases.
    Coloma PM; Avillach P; Salvo F; Schuemie MJ; Ferrajolo C; Pariente A; Fourrier-Réglat A; Molokhia M; Patadia V; van der Lei J; Sturkenboom M; Trifirò G
    Drug Saf; 2013 Jan; 36(1):13-23. PubMed ID: 23315292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propensity Score-Based Approaches in High Dimension for Pharmacovigilance Signal Detection: an Empirical Comparison on the French Spontaneous Reporting Database.
    Courtois É; Pariente A; Salvo F; Volatier É; Tubert-Bitter P; Ahmed I
    Front Pharmacol; 2018; 9():1010. PubMed ID: 30279658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection.
    Pacurariu AC; Straus SM; Trifirò G; Schuemie MJ; Gini R; Herings R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Arlett P; van der Lei J; Sturkenboom MC; Coloma PM
    Drug Saf; 2015 Dec; 38(12):1201-10. PubMed ID: 26370104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France.
    Pariente A; Avillach P; Salvo F; Thiessard F; Miremont-Salamé G; Fourrier-Reglat A; Haramburu F; Bégaud B; Moore N;
    Drug Saf; 2012 Oct; 35(10):855-64. PubMed ID: 22967190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.
    Raschi E; Poluzzi E; Salvo F; Koci A; Suling M; Antoniazzi S; Perina L; Hazell L; Moretti U; Sturkenboom M; Garbe E; Pariente A; De Ponti F
    Drug Saf; 2016 Jan; 39(1):59-68. PubMed ID: 26446144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statistical Signal Detection Algorithm in Safety Data: A Proprietary Method Compared to Industry Standard Methods.
    Bastos E; Allen JK; Philip J
    Pharmaceut Med; 2024 Jul; 38(4):321-329. PubMed ID: 39003400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple method for exploring adverse drug events in patients with different primary diseases using spontaneous reporting system.
    Noguchi Y; Ueno A; Otsubo M; Katsuno H; Sugita I; Kanematsu Y; Yoshida A; Esaki H; Tachi T; Teramachi H
    BMC Bioinformatics; 2018 Apr; 19(1):124. PubMed ID: 29621976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Substandard Medicines via Disproportionality Analysis of Individual Case Safety Reports.
    Trippe ZA; Brendani B; Meier C; Lewis D
    Drug Saf; 2017 Apr; 40(4):293-303. PubMed ID: 28130773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.
    Inch J; Watson MC; Anakwe-Umeh S
    Drug Saf; 2012 Oct; 35(10):807-18. PubMed ID: 22928729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential use of data-mining algorithms for the detection of 'surprise' adverse drug reactions.
    Hauben M; Horn S; Reich L
    Drug Saf; 2007; 30(2):143-55. PubMed ID: 17253879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of pharmacovigilance training of general practitioners: a retrospective cohort study in the Netherlands comparing two methods.
    Gerritsen R; Faddegon H; Dijkers F; van Grootheest K; van Puijenbroek E
    Drug Saf; 2011 Sep; 34(9):755-62. PubMed ID: 21830837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical Signal Process in R Language in the Pharmacovigilance Programme of India.
    Kumar A; Ahuja J; Shrivastava TP; Kumar V; Kalaiselvan V
    Ther Innov Regul Sci; 2018 May; 52(3):329-333. PubMed ID: 29714534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.